Health Boards
Sun-08-11-2015, 23:07 PM
Jim,
Roughly two thirds of patients saw a 20% reduction in symptoms of PsA - joint damage is just a part of the disease. They didn't report ARC 50. The results aren't better than the TNFs, so I wouldn't be shocked if TNFs is the first option (cheaper).
My own experience - this drug is stable for the back, but doesn't do as well for hands and feet. This drug does well for plaque psoriasis, but not as well as Stelara (maybe a dosage problem).
Roughly two thirds of patients saw a 20% reduction in symptoms of PsA - joint damage is just a part of the disease. They didn't report ARC 50. The results aren't better than the TNFs, so I wouldn't be shocked if TNFs is the first option (cheaper).
My own experience - this drug is stable for the back, but doesn't do as well for hands and feet. This drug does well for plaque psoriasis, but not as well as Stelara (maybe a dosage problem).
